866-997-4948(US-Canada Toll Free)

Europe Companion Diagnostic Cancer Biomarkers Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Cancer

No. of Pages : 119 Pages

Notes:
Sales, means the sales volume of Companion Diagnostic Cancer Biomarkers
Revenue, means the sales value of Companion Diagnostic Cancer Biomarkers

This report studies sales (consumption) of Companion Diagnostic Cancer Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Abbott Diagnostics
Agilent Technologies
Eli Lilly & Co.
EUSA Pharma
CytoCore, Inc.
GE Healthcare
Bruker Daltonics, Inc.
Biomarker Technologies, LLC
BioCurex, Inc.
Asuragen, Inc.
DiagnoCure, Inc.
Beckman Coulter, Inc.

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Companion Diagnostic Cancer Biomarkers in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by application, this report focuses on sales, market share and growth rate of Companion Diagnostic Cancer Biomarkers in each application, can be divided into
Colorectal
Prostate
Lung
Breast
Ovarian

Table of Contents

Europe Companion Diagnostic Cancer Biomarkers Market Report 2016
1 Companion Diagnostic Cancer Biomarkers Overview
1.1 Product Overview and Scope of Companion Diagnostic Cancer Biomarkers
1.2 Classification of Companion Diagnostic Cancer Biomarkers
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Companion Diagnostic Cancer Biomarkers
1.3.1 Colorectal
1.3.2 Prostate
1.3.3 Lung
1.3.4 Breast
1.3.5 Ovarian
1.4 Companion Diagnostic Cancer Biomarkers Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Companion Diagnostic Cancer Biomarkers (2011-2021)
1.5.1 Europe Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2021)
1.5.2 Europe Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)

2 Europe Companion Diagnostic Cancer Biomarkers by Manufacturers, Type and Application
2.1 Europe Companion Diagnostic Cancer Biomarkers Market Competition by Manufacturers
2.1.1 Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Companion Diagnostic Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Companion Diagnostic Cancer Biomarkers (Volume and Value) by Type
2.2.1 Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type (2011-2016)
2.2.2 Europe Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
2.3 Europe Companion Diagnostic Cancer Biomarkers (Volume and Value) by Countries
2.3.1 Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
2.4 Europe Companion Diagnostic Cancer Biomarkers (Volume) by Application

3 Germany Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
3.1 Germany Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
3.1.1 Germany Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
3.1.2 Germany Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
3.1.3 Germany Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
3.2 Germany Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
3.3 Germany Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
3.4 Germany Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

4 France Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
4.1 France Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
4.1.1 France Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
4.1.2 France Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
4.1.4 France Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
4.2 France Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
4.3 France Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
4.4 France Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

5 UK Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
5.1 UK Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
5.1.1 UK Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
5.1.2 UK Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
5.1.5 UK Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
5.2 UK Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
5.3 UK Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
5.4 UK Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

6 Russia Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
6.1 Russia Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
6.1.1 Russia Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
6.1.2 Russia Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
6.1.6 Russia Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
6.2 Russia Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
6.3 Russia Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
6.4 Russia Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

7 Italy Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
7.1 Italy Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
7.1.1 Italy Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
7.1.2 Italy Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
7.1.7 Italy Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
7.2 Italy Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
7.3 Italy Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
7.4 Italy Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

8 Spain Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
8.1 Spain Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
8.1.1 Spain Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
8.1.2 Spain Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
8.1.8 Spain Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
8.2 Spain Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
8.3 Spain Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
8.4 Spain Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

9 Benelux Companion Diagnostic Cancer Biomarkers (Volume, Value and Sales Price)
9.1 Benelux Companion Diagnostic Cancer Biomarkers Sales and Value (2011-2016)
9.1.1 Benelux Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
9.1.2 Benelux Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
9.2 Benelux Companion Diagnostic Cancer Biomarkers Sales and Market Share by Manufacturers
9.3 Benelux Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type
9.4 Benelux Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application

10 Europe Companion Diagnostic Cancer Biomarkers Manufacturers Analysis
10.1 Abbott Diagnostics
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Abbott Diagnostics Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Agilent Technologies
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Agilent Technologies Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Eli Lilly & Co.
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Eli Lilly & Co. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 EUSA Pharma
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 EUSA Pharma Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 CytoCore, Inc.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 CytoCore, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 GE Healthcare
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 GE Healthcare Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Bruker Daltonics, Inc.
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Bruker Daltonics, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Biomarker Technologies, LLC
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Biomarker Technologies, LLC Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 BioCurex, Inc.
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 BioCurex, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Asuragen, Inc.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Companion Diagnostic Cancer Biomarkers Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Asuragen, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 DiagnoCure, Inc.
10.12 Beckman Coulter, Inc.

11 Companion Diagnostic Cancer Biomarkers Manufacturing Cost Analysis
11.1 Companion Diagnostic Cancer Biomarkers Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Companion Diagnostic Cancer Biomarkers

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Companion Diagnostic Cancer Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Companion Diagnostic Cancer Biomarkers Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Companion Diagnostic Cancer Biomarkers Market Forecast (2016-2021)
14.1 Germany Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.2 France Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.3 UK Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.4 Russia Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.5 Italy Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.6 Spain Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.7 Benelux Companion Diagnostic Cancer Biomarkers Sales Forecast (2016-2021)
14.8 Europe Companion Diagnostic Cancer Biomarkers Sales Forecast by Type (2016-2021)
14.9 Europe Companion Diagnostic Cancer Biomarkers Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer


List of Table

List of Tables and Figures

Figure Picture of Companion Diagnostic Cancer Biomarkers
Table Classification of Companion Diagnostic Cancer Biomarkers
Figure Europe Sales Market Share of Companion Diagnostic Cancer Biomarkers by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Companion Diagnostic Cancer Biomarkers
Figure Europe Sales Market Share of Companion Diagnostic Cancer Biomarkers by Application in 2015
Figure Colorectal Examples
Figure Prostate Examples
Figure Lung Examples
Figure Breast Examples
Figure Ovarian Examples
Figure Germany Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure France Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure UK Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Russia Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Italy Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Spain Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Benelux Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Europe Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure Europe Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table Europe Companion Diagnostic Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Companion Diagnostic Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Companion Diagnostic Cancer Biomarkers Sales Share by Manufacturers
Table Europe Companion Diagnostic Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table Europe Companion Diagnostic Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Companion Diagnostic Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 Europe Companion Diagnostic Cancer Biomarkers Revenue Share by Manufacturers
Table Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share by Type (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Share by Type (2011-2016)
Figure Sales Market Share of Companion Diagnostic Cancer Biomarkers by Type (2011-2016)
Figure Europe Companion Diagnostic Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Companion Diagnostic Cancer Biomarkers by Type (2011-2016)
Figure Europe Companion Diagnostic Cancer Biomarkers Revenue Growth Rate by Type (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Share by Countries (2011-2016)
Figure Sales Market Share of Companion Diagnostic Cancer Biomarkers by Countries (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Companion Diagnostic Cancer Biomarkers by Countries (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales and Market Share by Application (2011-2016)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Share by Application (2011-2016)
Figure Sales Market Share of Companion Diagnostic Cancer Biomarkers by Application (2011-2016)
Figure Germany Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Germany Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Germany Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table Germany Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Germany Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Germany Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table Germany Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Germany Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table Germany Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure France Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure France Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure France Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table France Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table France Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table France Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table France Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table France Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table France Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure UK Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure UK Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure UK Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table UK Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table UK Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table UK Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table UK Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table UK Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table UK Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Russia Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Russia Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Russia Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table Russia Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Russia Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Russia Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table Russia Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Russia Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table Russia Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Italy Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Italy Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Italy Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table Italy Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Italy Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Italy Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table Italy Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Italy Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table Italy Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Spain Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Spain Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Spain Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table Spain Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Spain Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Spain Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table Spain Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Spain Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table Spain Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Benelux Companion Diagnostic Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Benelux Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Benelux Companion Diagnostic Cancer Biomarkers Sales Price Trend (2011-2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Sales by Type (2015 and 2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Sales by Application (2015 and 2016)
Table Benelux Companion Diagnostic Cancer Biomarkers Market Share by Application (2015 and 2016)
Table Companion Diagnostic Cancer Biomarkers Basic Information List
Table Abbott Diagnostics Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Diagnostics Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Eli Lilly & Co. Basic Information List
Table Eli Lilly & Co. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly & Co. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table EUSA Pharma Basic Information List
Table EUSA Pharma Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table CytoCore, Inc. Basic Information List
Table CytoCore, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytoCore, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Bruker Daltonics, Inc. Basic Information List
Table Bruker Daltonics, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bruker Daltonics, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Biomarker Technologies, LLC Basic Information List
Table Biomarker Technologies, LLC Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biomarker Technologies, LLC Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table BioCurex, Inc. Basic Information List
Table BioCurex, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioCurex, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Asuragen, Inc. Basic Information List
Table Asuragen, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Asuragen, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table DiagnoCure, Inc. Basic Information List
Table DiagnoCure, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table DiagnoCure, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Beckman Coulter, Inc. Basic Information List
Table Beckman Coulter, Inc. Companion Diagnostic Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beckman Coulter, Inc. Companion Diagnostic Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Companion Diagnostic Cancer Biomarkers
Figure Manufacturing Process Analysis of Companion Diagnostic Cancer Biomarkers
Figure Companion Diagnostic Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Companion Diagnostic Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Companion Diagnostic Cancer Biomarkers
Table Distributors/Traders List
Figure Germany Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Germany Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure France Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure France Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure UK Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure UK Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Russia Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Italy Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Spain Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Companion Diagnostic Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Companion Diagnostic Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Forecast by Type (2016-2021)
Table Europe Companion Diagnostic Cancer Biomarkers Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *